Upto 60% Off on UPSC Online Courses

Avail Now
Home  »   Current Affairs  »   Medicines Patent Pool

Medicines Patent Pool

June 23, 2023

Context: 

The Medicines Patent Pool (MPP) has signed sub licence agreements with the India based companies Eugia, Hetero and Dr. Reddy’s Laboratories, along with the Indonesian firm BrightGene, to make generic versions of the drug Nilotinib.

What is Nilotinib?

  • It is a drug used for the treatment of chronic myeloid leukaemia, a type of blood cancer.
  • Nilotinib is sold under the brand name Tasigna and marketed worldwide by Novartis- a Switzerland ­based pharmaceutical corporation.

About Medicines Patent Pool:

  • The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation.
  • Founded by: Unitaid.
  • Aim: 
    1. To increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. 
    2. To prioritise and licence needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
  • Multi Stakeholder partnership: Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders.

News Source: The Hindu

Print Friendly, PDF & Email

To get PDF version, Please click on "Print PDF" button.

Print Friendly, PDF & Email

Recent Editorial

UNION BUDGET 2024-25

The Issues With State-Sponsored Street Art

How children win with U-WIN, Govt’s new online v...

Benefits Of The Domestic Silk Route

Cops Can’t Force, Supreme Court Pauses Kanwa...

From Madhya Rekha to Sindhu-Sarasvati: Major shift...

Popular current affairs

News in Shorts: 24 July 2024

Climate Finance Taxonomy

Budget 2024–25: Unemployment

Supreme Court Split Verdict on GM Mustard Approval

Corridor Projects Announced for Bihar’s Vishnupa...

Webb Telescope On Cosmic Brown Dwarfs

Our Courses

Our Courses

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

# #
      
Subscribe our Newsletter
Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
*Promise! We won't spam you.
Yes! I want to Subscribe.

Contact Details

G-Floor,4-B Pusha Road, New Delhi, 110060

Download Our App

# #

 Final Result – CIVIL SERVICES EXAMINATION, 2023.   Udaan-Prelims Wallah ( Static ) booklets 2024 released both in english and hindi : Download from Here!     Download UPSC Mains 2023 Question Papers PDF  Free Initiative links -1) Download Prahaar 3.0 for Mains Current Affairs PDF both in English and Hindi 2) Daily Main Answer Writing  , 3) Daily Current Affairs , Editorial Analysis and quiz ,  4) PDF Downloads  UPSC Prelims 2023 Trend Analysis cut-off and answer key

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

# #
      
Follow Us:
Subscribe our Newsletter
Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
*Promise! We won't spam you.
Yes! I want to Subscribe.

Contact Details

Download Our App

# #

 Final Result – CIVIL SERVICES EXAMINATION, 2023.   Udaan-Prelims Wallah ( Static ) booklets 2024 released both in english and hindi : Download from Here!     Download UPSC Mains 2023 Question Papers PDF  Free Initiative links -1) Download Prahaar 3.0 for Mains Current Affairs PDF both in English and Hindi 2) Daily Main Answer Writing  , 3) Daily Current Affairs , Editorial Analysis and quiz ,  4) PDF Downloads  UPSC Prelims 2023 Trend Analysis cut-off and answer key
Quick Revise Now !
AVAILABLE FOR DOWNLOAD SOON
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध
Quick Revise Now !
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध

<div class="new-fform">







    </div>

    Subscribe our Newsletter
    Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
    *Promise! We won't spam you.
    Yes! I want to Subscribe.